[关键词]
[摘要]
目的:应用光学相干断层扫描血管成像(OCTA),分析服用羟氯喹(HCQ)患者黄斑区视网膜微循环的变化特征,探讨OCTA在HCQ相关视网膜毒性早期筛查中的应用价值。
方法:本研究为回顾性病例对照研究。收集2025年1月至2026年3月在连云港市第一人民医院就诊的风湿免疫性疾病患者(病例组)。这些患者均规律服用HCQ,且眼底检查未发现明显器质性异常。另收集年龄、性别等人口学特征相匹配的健康受检者作为对照组(A组)。病例组按HCQ服药时长分为2组:服药时长<5 a(B组)、服药时长≥5 a(C组)。所有参与者均行最佳矫正视力(BCVA)、频域光相干断层扫描(SD-OCT)、视野及眼底检查。通过OCTA测量黄斑中心6 mm×6 mm范围内各区域(中心凹、中心凹旁及中心凹周围)视网膜浅层毛细血管丛(SCP)血流密度、深层毛细血管丛(DCP)血流密度及黄斑中心凹无血管区(FAZ)面积、周长、血流密度及外层血流面积(flow area)并进行三组的比较。分析病例组视网膜各区域血流密度与HCQ服药时长的相关性。
结果:本研究共纳入60例参与者,平均年龄43.53±9.67岁,其中男8例,女52例。A组19例(平均年龄43.74±10.64岁,男3例,女16例),B组19例(平均年龄43.74±12.70岁,男3例,女16例),C组22例(平均年龄43.82±6.84岁,男2例,女20例)。C组黄斑区视网膜DCP血流密度较A组显著降低(均P<0.05); 三组间SCP血流密度比较无差异(均P>0.05); 服用HCQ患者视网膜各区域(整体、上半区、下半区、中心凹、中心凹旁、中心凹周围)DCP血流密度与HCQ服药时长呈负相关(rs=-0.176、-0.219、-0.184、-0.317、-0.436、-0.259,均P<0.05)。
结论:OCTA可检测到长期服用HCQ的风湿免疫性疾病患者黄斑区DCP血流密度降低,该指标与服药时长呈负相关,提示OCTA有潜力成为HCQ视网膜毒性早期筛查的补充工具。
[Key word]
[Abstract]
AIM:To assess macular retinal microcirculatory changes in patients receiving hydroxychloroquine(HCQ)using optical coherence tomography angiography(OCTA)and to explore the potential value of OCTA for early screening of HCQ-related retinal toxicity.
METHODS: This was a retrospective case-control study. Patients with rheumatic autoimmune diseases who were regularly taking HCQ and had no obvious organic abnormalities on fundus examination were enrolled as the case group from January 2025 to March 2026 at the First People's Hospital of Lianyungang. Healthy participants matched for age, sex and other demographic characteristics were recruited as the control group(Group A). The case group was further divided into two subgroups according to HCQ treatment duration: duration <5 y(Group B)and duration ≥5 y(Group C). All participants underwent best-corrected visual acuity(BCVA), spectral-domain optical coherence tomography(SD-OCT), visual field and fundus examinations. OCTA was adopted to measure vessel density of the superficial capillary plexus(SCP)and deep capillary plexus(DCP), as well as the area, perimeter, vessel density and outer flow area of the foveal avascular zone(FAZ)in each region(fovea, parafovea and perifovea)within the 6 mm ×6 mm macular scan area. The above parameters were compared among the three groups. The correlations between regional retinal vessel density and HCQ treatment duration in the case group were analyzed.
RESULTS: Totally 60 participants(8 males and 52 females)were enrolled in this study, with a mean age of 43.53±9.67 y. Group A consisted of 19 participants(mean age 43.74±10.64 y; 3 males, 16 females), Group B consisted of 19 participants(mean age 43.74±12.70 y; 3 males, 16 females), and Group C consisted of 22 participants(mean age 43.82±6.84 y; 2 males, 20 females). Macular DCP vessel density was significantly lower in Group C than in Group A(P<0.05). SCP vessel density did not differ significantly among the three groups(all P>0.05).Regional DCP vessel density in the whole area, superior hemifield, inferior hemifield, fovea, parafovea, and perifovea was negatively correlated with HCQ treatment duration in HCQ-treated patients(rs=-0.176,-0.219,-0.184,-0.317,-0.436,-0.259, respectively; all P<0.05).
CONCLUSIONS:OCTA can detect decreased macular DCP vessel density in patients with rheumatic autoimmune diseases receiving long-term HCQ. DCP vessel density is negatively correlated with treatment duration, suggesting that OCTA has the potential to be an adjunctive tool for screening HCQ-related retinal toxicity.
[中图分类号]
[基金项目]